tldrdailynews.com logo

EU Finds Rare Eye Risks in Ozempic and Other GLP-1 Diabetes Drugs

1 min read
Source: politico.eu
EU Finds Rare Eye Risks in Ozempic and Other GLP-1 Diabetes Drugs
Photo: politico.eu
TL;DR

The EU drugs regulator has identified a 'very rare' side effect of Ozempic, which can cause sight loss, highlighting the importance of monitoring adverse effects of medications.

Topics:top-newshealth#eu-regulator#health#ozempic#rare#side-effect#sight-loss
Share this article
  1. Ozempic has ‘very rare’ sight loss side effect, EU drugs regulator finds  politico.eu
  2. Weight loss drugs linked to higher risk of eye damage in diabetic patients  The Guardian
  3. Novo's Ozempic linked to rare cases of serious eye disorder, EU regulator says  Reuters
  4. A kidney disease showdown, and eye risk linked to GLP-1s  statnews.com
  5. Diabetes patients who use GLP-1s may have a higher risk of serious eye disease: study  Fierce Pharma

Want the full story? Read the original reporting

Read on politico.eu